Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17034203 | 0.86 | KDM4E (0.39) | ALDH1A1RECQLMEN1KMT2ALMNA | |
| SCHEMBL17034207 | 0.86 | RXFP1 (0.32) | RXFP1ALDH1A1 | |
| SCHEMBL17034266 | 0.82 | NAAA (0.38) | NAAARXFP1ALDH1A1MAPTRECQL | |
| SCHEMBL19600845 | 0.82 | ALDH1A1 (0.40) | NAAARXFP1ALDH1A1MEN1KMT2A | |
| SCHEMBL19600843 | 0.78 | ALDH1A1 (0.44) | NAAARXFP1ALDH1A1MEN1KMT2A | |
| SCHEMBL19600831 | 0.78 | ALDH1A1 (0.44) | NAAARXFP1ALDH1A1MEN1KMT2A | |
| SCHEMBL17034112 | 0.77 | GLA (0.39) | RXFP1ALDH1A1MEN1KMT2ANPSR1 | |
| SCHEMBL16252218 | 0.76 | ALDH1A1 (0.33) | ALDH1A1MAPTRECQLL3MBTL1NPSR1 | |
| SCHEMBL14716279 | 0.74 | PTGS1 (0.37) | ALDH1A1HPGDTSHRCDC25A | |
| SCHEMBL14716581 | 0.74 | PTGS1 (0.37) | ALDH1A1HPGDTSHRCDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10629815-B2 | Conjugated polymers | INNOVATIONLAB GMBH (DE) | 2020-04-21 | — | — | US | disclosed |
| US-20170331043-A1 | CONJUGATED POLYMERS | INNOVATIONLAB GMBH (DE) | 2017-11-16 | — | — | US | disclosed |
| US-20170331043-A1 | CONJUGATED POLYMERS | INNOVATIONLAB GMBH (DE) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10629815-B2 | Conjugated polymers | CDH1, OCIAD2, OCIAD1 | NAAA 1129/4885RXFP1 4060/4885ALDH1A1 4000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.